BRIEF-OPKO Health’S Modex Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study In Collaboration With Merck

Reuters
07 Jan
BRIEF-OPKO Health’S Modex <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study In Collaboration With Merck

Jan 7 (Reuters) - Merck & Co Inc MRK.N:

  • OPKO HEALTH’S MODEX THERAPEUTICS ANNOUNCES EPSTEIN-BARR VIRUS VACCINE CANDIDATE ENTERS PHASE I CLINICAL STUDY IN COLLABORATION WITH MERCK

  • MODEX THERAPEUTICS- DEVELOPMENT TRIGGERS UNDISCLOSED MILESTONE PAYMENT FROM MERCK

Source text: ID:nGNX2HjPby

Further company coverage: MRK.N

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10